SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
Speculative Growth Leadership Wiped Out
ALXN
|
|
|
-8.54%
in
29 days
(closed on 11/25/08)
There is nothing I can write to do justice to the trading that has unfolded over recent months: wholesale, rampant distribution, outright institutional liquidation. The US Government, my golly, THE GOVERNMENT has invested TAX PAYER money to prop up stocks. The market has reacted with one of the most violent crashes, yes, CRASHES, modern markets have ever seen. <> I have stared wide-eyed at violent down then up then down swings on nauseating volume. Then I have gone about my business safe in the knowledge that I have almost no skin in the game. As a stock trader of ten years now, I am humble...
|
ALXN $6 to $12 Target Price Range - Overvalued in Industry
ALXN
|
|
|
-21.48%
in
380 days
ALXN's projected P/E is 49.50
Industry (Drug Manufacturers - Other) average projected P/E 16.16
Implies a projected stock price of $12.93 ALXN's PEG is 11.27
ALXN's projected earnings growth rate is 4.39%
Industry (Drug Manufacturers - Other) average PEG is 1.86
Implies a projected stock price of $6.54 More analysis source, calculations, and other info: http://www.freestockvalueranker.com/?method=peg_pe&symbol... Analysis current as of October 23, 2008 5:00 PM
|
Bullish on ALXN ...
ALXN
|
|
|
+1.37%
in
8 days
(closed on 10/22/08)
First in class, fully humanized monoclonal antibody, and a number of early stage products. Looks good to me.
|
Who's Next in the Biotech Buyout Frenzy?
ALXN
|
|
|
+30.04%
in
390 days
<> The biotech industry is rapidly consolidating as big pharma companies put their cash stash to use in deals ranging from well-known large caps all the way down to unknown micro-caps in an effort to bolster their range of marketed products, late stage pipeline candidates, and drug discovery technology platforms.
Genentech (DNA) has rejected Roche's (RHHBY) $89 bid to acquire the remaining 44% of DNA it does not already own as insufficient. I think DNA could easily get $100 per share based on Eli Lilly's (LLY) $70 buyout of ImClo...
|
From the Blogosphere
Trading Radar for 10/22: AT&T (T), McDonalds (MCD), Amazon.com (AMZN), 3M (MMM), Dow Chemical (DOW), UPS (UPS) Report
The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session:<u>Before Market Opens:</u>Economics:8:30am ET- Initial Jobless Claims – Street Sees 517K
Earnings:Akeena Solar (NASDAQ: AKNS) – consensus loss $0.10Alaska Air Group, Inc. (NYSE: ALK) – consensus EPS $2.26Alexion Pharmaceuticals (NASDAQ: ALXN) - consensus EPS $0.21AT&T (NYSE: T) - consensus EPS $0.50Bunge Limited (NYSE: BG) – consensus EPS $1.47Cabot Microelectronics(NASDAQ: CCMP) – consensus EPS $0.36Cash America International (NYSE: CSH) – consensus $0.72CONMED (NASDAQ: CNMD) – consensus EPS...
|
Stem Cell Stocks Update
|
|
|
Today, Monday, March 9, President Barack Obama will be signing an executive order to eliminate a ban on federal funding for embryonic stem-cell research. This major change in policy will cause the research into stem cell therapy to increase substantially. Research has been continuing to utilize stem cells for gene therapy and the treatment of Parkinson’s disease, heart disease, diabetes, multiple sclerosis, arthritis, and many other medical conditions.
Stem cells can come from embryos and from cord blood, the blood from umbilical cords, and even in baby teeth.
Alexion Pharmaceuticals...
|
A Reader Writes "CTSH, HAE, and ALXN---Your Thoughts?"
|
|
|
Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on this website.  My loyal reader and commenter, Doug S., who has suggested many a good idea dropped me a line last week and wrote:
"CTSH looks like a screaming buy. HAE has been behaving well, and ALXN looks very interesting and insulated from the economic fiasco. No current positions."
<>First of all, thank you ...
|
Health Care Sector Still See Positive Earnings
|
|
|
- Health care sector is a clear winner.
- Low budget restaurants, food processing, cheap house products companies saw in-line earnings.
- Communications, hotel, digita media industry saw negative earnings.
POSITIVE EARNINGS
APCapital Sees Earnings Above Estimates
American Physicians Capital (ACAP) said it expects 2009 earnings of at least $4.25 per share. The current consensus earnings estimate is $4.23 per share for the year ending December 31, 2009.
Emergency Medical Services Guides Above Estimates
Emergency Medical Services (EMS) said it expects 2009 earnings of $2.05 to $2.15 per share. The current ...
|
|
By
s J
(-18.05% risk: aggressive)
02/13/09
|
Comment
|
Analyst upgrades, downgrades and initiations: ADBE, PFE, WYE, BHP
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on ALXN |
Visit streetinsider.com
Be the first to start a discussion and earn 2 points.
More Resources
|
About Alexion Pharmaceuticals Inc.
- Answers.com
